Table 3.
Coefficient | 95% CI | p Value | |
---|---|---|---|
Mean CIMT (mm) | |||
Age, years | 0.006 | 0.005 to 0.007 | <0.001 |
Gender, woman | 0.01 | −0.02 to 0.04 | 0.70 |
Systolic blood pressure, mm Hg | 0.001 | −0.001 to 0.002 | 0.10 |
LDL, mg/dl | 0.0002 | −0.001 to 0.001 | 0.39 |
HDL, mg/dl | 0.001 | −0.001 to 0.002 | 0.43 |
Body mass index, kg/m2 | −0.002 | −0.005 to 0.001 | 0.25 |
HOMA-IR, mmol/l×μU/ml | 0.002 | −0.003 to 0.007 | 0.49 |
Antihypertensive medication use | 0.04 | −0.02 to 0.10 | 0.15 |
Chronic exposure to biomass fuels | 0.03 | 0.01 to 0.06 | 0.02 |
Maximum CIMT (mm) | |||
Age, years | 0.007 | 0.006 to 0.008 | <0.001 |
Gender, woman | 0.01 | −0.02 to 0.04 | 0.58 |
Systolic blood pressure, mm Hg | 0.001 | −0.001 to 0.002 | 0.07 |
LDL, mg/dl | 0.0002 | −0.001 to 0.001 | 0.27 |
HDL, mg/dl | 0.001 | −0.001 to 0.002 | 0.39 |
Body mass index, kg/m2 | −0.002 | −0.004 to 0.001 | 0.45 |
HOMA-IR, mmol/l×μU/ml | 0.003 | −0.01 to 0.01 | 0.37 |
Antihypertensive medication use | 0.05 | −0.01 to 0.11 | 0.16 |
Chronic exposure to biomass fuels | 0.03 | 0.01 to 0.06 | 0.04 |
Systolic blood pressure (mm Hg) | |||
Age, years | 0.52 | 0.37 to 0.67 | <0.001 |
Gender, woman | −8.1 | −11.6 to −4.6 | <0.001 |
LDL, mg/dl | 0.04 | −0.01 to 0.09 | 0.11 |
HDL, mg/dl | 0.04 | −0.13 to 0.21 | 0.67 |
Body mass index, kg/m2 | 0.59 | 0.10 to 1.08 | 0.02 |
HOMA-IR, mmol/l×μU/ml | 0.64 | −0.14 to 1.42 | 0.11 |
Antihypertensive medication use | 6.6 | −1.8 to 15.0 | 0.12 |
Chronic exposure to biomass fuels | 9.2 | 5.4 to 13.0 | <0.001 |
Diastolic blood pressure (mm Hg) | |||
Age, years | 0.10 | 0.01 to 0.19 | 0.04 |
Gender, woman | −4.0 | −6.2 to −1.8 | <0.001 |
LDL, mg/dl | 0.03 | −0.01 to 0.06 | 0.11 |
HDL, mg/dl | 0.01 | −0.99 to 1.01 | 0.86 |
Body mass index, kg/m2 | 0.62 | 0.31 to 0.93 | <0.001 |
HOMA-IR, mmol/l×μU/ml | 0.26 | −0.23 to 0.75 | 0.29 |
Antihypertensive medication use | 3.1 | −2.1 to 8.3 | 0.25 |
Chronic exposure to biomass fuels | 6.5 | 4.1 to 8.9 | <0.001 |
| |||
OR | 95% CI | p Value | |
| |||
Carotid artery atherosclerotic plaque | |||
Age, years | 1.08 | 1.05 to 1.12 | <0.001 |
Gender, woman | 0.55 | 0.27 to 1.11 | 0.10 |
Systolic blood pressure, mm Hg | 1.00 | 0.97 to 1.02 | 0.80 |
LDL, mg/dl | 1.01 | 1.00 to 1.02 | 0.08 |
HDL, mg/dl | 0.97 | 0.94 to 1.00 | 0.08 |
Body mass index, kg/m2 | 1.02 | 0.92 to 1.13 | 0.68 |
HOMA-IR, mmol/l×μU/ml | 1.01 | 0.88 to 1.17 | 0.84 |
Antihypertensive medication use | 1.66 | 0.40 to 6.8 | 0.48 |
Chronic exposure to biomass fuels | 2.55 | 1.08 to 5.98 | 0.03 |
HDL, high-density lipoprotein; HOMA-IR, Homeostasis model of assessment-insulin resistance; LDL, low-density lipoprotein.